Erkrankungen der Harnwege und der Prostata
- 30 April 2025
- book chapter
- Published by Springer Nature
- p. 691-702
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Anticholinergic Drugs for Overactive Bladder in Frail Older Patients: The Case AgainstDrugs & Aging, 2018
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?Reviews in Endocrine and Metabolic Disorders, 2015
- Which anticholinergic drug for overactive bladder symptoms in adultsCochrane Database of Systematic Reviews, 2012
- Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in EuropeEuropean Urology, 2011
- The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT StudyEuropean Urology, 2010
- Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults2006
- Anticholinergic drugs versus placebo for overactive bladder syndrome in adultsCochrane Database of Systematic Reviews, 2006
- Which anticholinergic drug for overactive bladder symptoms in adults2005
- Darifenacin, an M3 Selective Receptor Antagonist, is an Effective and Well-Tolerated Once-Daily Treatment for Overactive BladderEuropean Urology, 2004
- Medical treatment and medical side effects in urinary incontinence in the elderlyWorld Journal of Urology, 1998